BRIEF-Biocardia Submits Cardiamp Hf Clinical Study Data To FDA

BioCardia, Inc. +5.93%

BioCardia, Inc.

BCDA

1.25

+5.93%

- BioCardia Inc BCDA.O:

  • BIOCARDIA INC - SUBMITS CARDIAMP HF CLINICAL STUDY DATA TO FDA - SEC FILING

  • BIOCARDIA INC - PLANS FDA MEETING ON ACCELERATED APPROVAL PATHWAY FOR CARDIAMP SYSTEM IN HFREF - SEC FILING

Source text: [ID:n0001437749-26-010967]

Further company coverage: BCDA.O